Evidence-Based Medicine Guidelines
Interferon beta for secondary progressive multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon Beta for Secondary Progressive Multiple Sclerosis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis.
Interferon beta for secondary progressive multiple sclerosis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis. Accessed March 17, 2025.
Interferon beta for secondary progressive multiple sclerosis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis
Interferon Beta for Secondary Progressive Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon beta for secondary progressive multiple sclerosis
ID - 457582
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
